medigraphic.com
Colegio de Medicina Interna de México.

2024, Number 1

<< Back Next >>

Med Int Mex 2024; 40 (1)

Severe pneumonia due to COVID-19 and coinfection by coccidioidomycosis

López JF, Saucedo AAG, Ramírez VSD, Antúnez MC, Lozano JA

Language: Spanish
References: 19
Page: 71-77
PDF size: 523.03 Kb.


ABSTRACT

Background: COVID-19 is a disease characterized by typical and atypical findings on imaging studies, which may or may not lead to severe acute respiratory syndrome. COVID-19 symptoms of most patients are very similar to those of other respiratory infections. Being in a pandemic, the centralization of management and treatment around it is common. However, this circumstance should not make us forget the rest of the respiratory diseases.
Clinical case: A 57-year-old male, without comorbidities, positive SARS-CoV-2
Conclusions: In patients with COVID-19, the possibility of co-infection with other pathogens should always be investigated so that treatment guidelines are timely and cover both causes from the early stages of the disease.


REFERENCES

  1. Chu DT, Vu Ngoc SM, Vu Thi H, Nguyen Thi YV, Ho TT, HoangVT, Singh V, Al-Tawfiq JA. COVID-19 in Southeast Asia:current status and perspectives. Bioengineered 2022; 13(2): 3797-3809. doi: 10.1080/21655979.2022.2031417.

  2. Shan S, Guangming L, Wei L, Xuedong Y. Spontaneouspneumomediastinum, pneumothorax and subcutaneousemphysema in COVID-19: case report and literature review.Rev Inst Med Trop Sao Paulo 2020; 62: e76. doi: 10.1590/S1678-9946202062076.

  3. World Healt Organization. Coronavirus disease (COVID-19).Tablero de emergencias sanitarias WHO. https://covid19.who.int/region/amro/country/mx.

  4. Dios Guillán V, Matellanes Palacios M, Bou Boluda L, PontSanjuan V. No todo es COVID-19, aunque lo parezca [Noteverything is COVID-19 - though it might seem so]. ActasDermosifiliogr 2021. doi: 10.1016/j.ad.2021.10.005.

  5. Roussey JA, Olszewski MA, Osterholzer JJ. Immunoregulationin fungal diseases. Microorganisms 2016; 4: 47.https://doi.org/10.3390/microorganisms4040047.

  6. Lin PL, Flynn JL. Understanding latent tuberculosis: amoving target. J Immunol 2010; 185: 15-22. doi: 10.4049/jimmunol.0903856.

  7. Chen JC, Wong D, Rabi S, Worswick S, DeClerck B, Gibb J.All that coughs is not COVID-19: A delayed diagnosis ofdisseminated coccidioidomycosis following severe acuterespiratory syndrome coronavirus 2 infection. Open ForumInfect Dis 2021; 8 (7). https://doi.org/10.1093/ofid/ofab246.

  8. Krauth DS, Jamros CM, Rivard SC, Olson NH, Maves RC. Acceleratedprogression of disseminated coccidioidomycosisfollowing SARS-CoV-2 infection: A case report. Mil Med 2021;186 (11-12): 1254-1256. doi: 10.1093/milmed/usab132.

  9. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, WangT, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, SongJ, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical andimmunological features of severe and moderate coronavirusdisease 2019. J Clin Invest 2020; 130 (5): 2620-2629.doi:10.1172/JCI137244.

  10. Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinityof COVID-19: immunity, inflammation and intervention.Nat Rev Immunol 2020; 20 (6): 363-374. doi: 10.1038/s41577-020-0311-8.

  11. Pemán J, Ruiz-Gaitán A, García-Vidal C, Salavert M, RamírezP, Puchades F, García-Hita M, Alastruey-Izquierdo A, QuindósG. Fungal co-infection in COVID-19 patients: Should webe concerned? Rev Iberoam Micol 2020; 37 (2): 41-46. doi:10.1016/j.riam.2020.07.001.

  12. COVID-19 Treatment Guidelines Panel. Coronavirus Disease2019 (COVID-19) Treatment Guidelines. National Institutesof Health. https://www.covid19treatmentguidelines.nih.gov/.

  13. Nielsen MC, Reynoso D, Ren P. 2021. The brief case: Afatal case of SARS-CoV-2 coinfection with Coccidioides inTexas— another challenge we face. J Clin Microbiol 2021;59:e00163-21. https://doi.org/10.1128/JCM.00163-21.

  14. Sous R, Sharma R, Amodio D, Heidari A. Two cases ofmiliary and disseminated coccidioidomycosis followingglucocorticoid therapy and literature review. J InvestMed High Impact Case Reports 2022; 10: 1-7. https://doi:10.1177/23247096211051928.

  15. Huff D, Ampel NM, Blair JE. Coccidioidomycosis and COVID-19 Infection. An analysis from a single medical centerwithin the coccidioidal endemic area. Mycopathologia2022; 187: 199-204. https://doi.org/10.1007/s11046-022-00629-6.

  16. Chang CC, Senining RKJ, Goyal R. An acute pulmonarycoccidioidomycosis coinfection in a patient presentingwith multifocal pneumonia with COVID-19. J InvestMed High Impact Case Reports 2020; 8: 1-3. https://doi:10.1177/2324709620972244.

  17. Heaney AK, Head JR, Broen K, Click K, Taylor J, Balmes JR, etal. Coccidioidomycosis and COVID-19 co-infection, UnitedStates, 2020. Emerg Infect Dis 2020; 27 (5): 1266-1273.https://doi.org/10.3201/eid2705.204661.

  18. Johnson WM. Occupational factors in coccidioidomycosis.J Occup Med 1981; 23 (5): 367-74.

  19. Pathak L, Gayan S, Pal B, Talukdar J, Bhuyan S, Sandhya S,Yeger H, Baishya D, Das B. Coronavirus activates an altruisticstem cell-mediated defense mechanism that reactivatesdormant tuberculosis: Implications in coronavirus disease 2019 pandemic. Am J Pathol 2021; 191 (7): 1255-1268.doi:10.1016/j.ajpath.2021.03.011.




2020     |     www.medigraphic.com